Non-invasive, AI-enabled product helps CT readers to accurately*, efficiently, and consistently identify narrowings in the coronary arteries, advancing the HeartFlow portfolioMOUNTAIN VIEW, Calif ...

Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

RELATED: HeartFlow raises $240M to push coronary disease test In total, HeartFlow will rack up an estimated $709 million, split between the gross proceeds of Longview’s trust holdings and a ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of John Farquhar as Chief Operating Officer, effe.

HeartFlow, Inc., a leader in revolutionizing precision heartcare, and MedAxiom, an American College of Cardiology (ACC) company whose mission is to tr ...

REDWOOD CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Wayne J. Riley, MD, to its Board of ...